The Marcus (MCS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting will be held virtually on May 7, 2025, with shareholders voting on director elections, an omnibus incentive plan, executive compensation, and auditor ratification.
Shareholders of record as of March 5, 2025, are entitled to vote, with Class B shares carrying ten votes per share and Common shares one vote per share.
The board recommends voting in favor of all proposals, including the new incentive plan and executive compensation.
Voting matters and shareholder proposals
Proposals include electing ten directors, approving the 2025 Omnibus Incentive Plan, an advisory vote on executive compensation, and ratifying Deloitte & Touche LLP as auditor.
No shareholder proposals or director nominations were received for this meeting.
The new incentive plan authorizes up to 2,000,000 shares for equity and cash awards, replacing the prior plan.
Board of directors and corporate governance
Six of ten directors are independent under NYSE and SEC rules; the CEO also serves as board chairman.
Philip L. Milstein serves as Lead Independent Director, facilitating communication between independent directors and management.
The board has Audit, Compensation, Corporate Governance and Nominating, and Finance Committees, all with written charters.
Directors are expected to attend annual meetings; seven attended in 2024.
Latest events from The Marcus
- 2025 revenue reached $758.5M with strong theatre and hotel performance and robust growth outlook.MCS
Investor presentation5 Mar 2026 - Both divisions outperformed their industries, with strong revenue growth and a robust 2026 outlook.MCS
Q4 202526 Feb 2026 - Q2 revenue dropped 15%, but hotels outperformed and group bookings surged as theatres rebounded.MCS
Q2 20242 Feb 2026 - Record Q3 revenue, earnings, and industry outperformance with a strengthened capital structure.MCS
Q3 202417 Jan 2026 - Q4 revenue up 16.6% and record hotel results, with strong momentum for 2025 growth.MCS
Q4 202423 Dec 2025 - Shelf registration enables up to $150M in securities offerings and 5M-share secondary sales.MCS
Registration Filing16 Dec 2025 - Virtual annual meeting to vote on directors, incentive plan, pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Q1 revenue up 7.4%, but net loss widened to $16.8M; strong outlook for films and hotels.MCS
Q1 202519 Nov 2025 - Q2 2025 revenue up 17%, profit returns, theatres lead growth, CapEx to decline post-2025.MCS
Q2 202516 Nov 2025